A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis.

Jacob PendergrastChantal ArmaliJeannie L Callum Christine M Cserti-GazdewichAziz JiwajeeLani LiebermanWendy LauYulia LinNagina ParmarKaterina PavenskiLorna Sampson RidenNadine ShehataKezia Willie-RamharackGeorge A TomlinsonTik Nga TongBeth BinningtonDonald R Branchnull null

Published in: Transfusion (2021)

IVIG-mediated hemolysis is common and frequently severe. Monitoring for 5-10 days following an infusion should be considered in non-O patients receiving high-dose IVIG with known risk factors.

Keyphrases

high dose
risk factors
low dose
stem cell transplantation
red blood cell
early onset